| RS377721813 |
EIF2AK1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS377721888 |
RFX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Monogenic diabetes |
| RS377722320 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS377722423 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS377722465 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 5 |
| RS377722824 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS377723386 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Inborn genetic diseases |
| RS377723772 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS377723973 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS377724112 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS377724143 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS377724489 |
SLC22A5
|
Health Risk |
Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS377725187 |
POMK
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS377725442 |
THAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Torsion dystonia 6, Torsion dystonia 6 |
| RS377725666 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS377726143 |
FKBP10
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS377726262 |
EPG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vici syndrome, Inborn genetic diseases |
| RS377726402 |
WFS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Wolfram syndrome 1, Optic neuropathy |
| RS377727537 |
GPSM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Chudley-McCullough syndrome, Chudley-McCullough syndrome |
| RS377728296 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 4, Senior-Loken syndrome 4 |
| RS377729111 |
AP3B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 48 |
| RS377729736 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, CFTR-related disorder |
| RS377729741 |
DGAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS377730376 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome, Inborn genetic diseases |
| RS377730553 |
NBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Microcephaly |
| RS377730576 |
CNGB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia 3, Severe early-childhood-onset retinal dystrophy |
| RS377730779 |
SCN4B
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 10, Cardiovascular phenotype |
| RS377731205 |
WDR62
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 2, primary |
| RS377731576 |
TMC1
|
Health Risk |
Likely pathogenic |
— |
| RS377732929 |
EFHC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Absence seizure, EFHC1-related disorder |
| RS377732984 |
PACS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 66 |
| RS377734247 |
L2HGDH
|
Health Risk |
Conflicting classifications of pathogenicity |
L-2-hydroxyglutaric aciduria, Inborn genetic diseases |
| RS377734587 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, CBL-related disorder |
| RS377734748 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS377734902 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, Decreased circulating carnitine concentration |
| RS377735262 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS377736321 |
KCNJ13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS377736535 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS377736828 |
RRM2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 8a, Progressive external ophthalmoplegia with mitochondrial DNA deletions |
| RS377737248 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, Inborn genetic diseases |
| RS377737331 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS377737395 |
OFD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Orofaciodigital syndrome I, Joubert syndrome |
| RS377739292 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS377740590 |
TSEN54
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS377742193 |
CFHR3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS377742483 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 17, Joubert syndrome 17 |
| RS377743610 |
CFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Basal laminar drusen, Factor H deficiency |
| RS377745062 |
TRPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS377745426 |
POLR2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities |
| RS377745688 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 1 |
| RS377745714 |
DDX41
|
Health Risk |
Pathogenic/Likely pathogenic |
Acute myeloid leukemia, DDX41-related hematologic malignancy predisposition syndrome |
| RS377746889 |
GNB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate F, Charcot-Marie-Tooth disease dominant intermediate F |
| RS377747123 |
YEATS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, familial adult myoclonic |
| RS377747403 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome |
| RS377747439 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS377747563 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
RAI1-related disorder, RAI1-related disorder |
| RS377748152 |
TRIOBP
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS377748878 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2Q, Epidermolysis bullosa simplex 5B |
| RS377748897 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, NEB-related disorder |
| RS377749094 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS377749481 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS377749878 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
PCNT-related disorder, PCNT-related disorder |
| RS377749969 |
TRIOBP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS377750405 |
ANKS6
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 16, Nephronophthisis 16 |
| RS377750953 |
CEACAM16
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS377751310 |
GLDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Glycine encephalopathy |
| RS377752443 |
FIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS377752596 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS377754606 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS377754692 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, Cardiomyopathy |
| RS377755503 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiofaciocutaneous syndrome 4 |
| RS377756089 |
STAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS377756881 |
CACNA2D4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal cone dystrophy 4, Retinal cone dystrophy 4 |
| RS377757018 |
DOK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 10 |
| RS377757393 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS377757894 |
PGAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasia with intellectual disability syndrome 3, Hyperphosphatasia with intellectual disability syndrome 3 |
| RS377757978 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS377759037 |
FBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS377759571 |
MYOT
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 3, Myofibrillar myopathy 3 |
| RS377760437 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS377761767 |
OTOGL
|
Health Risk |
Likely pathogenic |
— |
| RS377762182 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 9, Complement component 3 deficiency |
| RS377762611 |
SLC29A3
|
Health Risk |
Pathogenic |
H syndrome, H syndrome |
| RS377763336 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS377763372 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica inversa, autosomal recessive |
| RS377763795 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS377764395 |
AARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 8, Combined oxidative phosphorylation defect type 8 |
| RS377767323 |
SMAD4
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Hereditary cancer-predisposing syndrome |
| RS377767326 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS377767327 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS377767328 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS377767331 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS377767332 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS377767333 |
SMAD4
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Hereditary cancer-predisposing syndrome |
| RS377767334 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis of stomach, Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome |
| RS377767335 |
SMAD4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS377767336 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS377767341 |
SMAD4
|
Health Risk |
Pathogenic |
— |
| RS377767343 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS377767344 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |